Viewing Study NCT04503694


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-03-10 @ 8:37 PM
Study NCT ID: NCT04503694
Status: RECRUITING
Last Update Posted: 2025-03-05
First Post: 2020-07-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Regorafenib in Combination with Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer
Sponsor: Jules Bordet Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Rectal Cancer Stage II View
None Rectal Cancer Stage III View
Keywords: